Skip to main content
Gaurav Goyal, MD, Oncology, Birmingham, AL

GauravGoyalMD

Oncology Birmingham, AL

Hematologic Oncology

Assistant Professor

Dr. Goyal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goyal's full profile

Already have an account?

  • Office

    1717 6th Ave S
    Birmingham, AL 35233
    Phone+1 800-822-8816

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • Creighton University School of Medicine (Omaha)
    Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2013 - 2016
  • N.H.L Municipal Medical College
    N.H.L Municipal Medical CollegeClass of 2011

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2022 - 2026
  • GA State Medical License
    GA State Medical License 2022 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2025
  • AL State Medical License
    AL State Medical License 2019 - 2024
  • MN State Medical License
    MN State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Time to first treatment is an independent prognostic factor for multiple myeloma (MM). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Adult Langerhans cell histiocytosis: A contemporary single-institution series of 186 patients. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • New Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers
    New Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined CancersMarch 1st, 2021